T1 Species 868 873 mouse
T2 Biomarker 1907 1916 Metformin
T3 Intervention 1849 1854  TAMs
T4 Condition 925 951 tumor extracellular matrix
T5 Protein 953 956 ECM
T6 Disease 776 788 inflammation
T7 Condition 1546 1557 desmoplasia
T8 Protein 384 405 glucose-lowering drug
T10 Disease 137 149 inflammation
T11 Condition 1300 1305 tumor
T12 Disease 1171 1183 inflammation
T13 Intervention 1317 1328 macrophages
T14 Intervention 1081 1099 HA and collagen-I 
T17 Condition 173 184 desmoplasia
T18 Biomarker 1710 1719 Metformin
T19 Level 1330 1334 TAMs
T20 Protein 1606 1609 ECM
T21 Condition 1111 1114 PSC
T22 Condition 792 796 PDAC
T23 Gene_or_gene_product 798 805 Methods
T25 Condition 443 478 diabetic pancreatic cancer patients
T26 Intervention 1025 1034 metformin
T28 Protein 1450 1455 STAT3
T29 Condition 2005 2013 patients
T30 Intervention 1144 1153 metformin
T31 Condition 837 841 PDAC
T32 Condition 470 478 patients
T33 Protein 1247 1252 IL-1β
T34 Condition 1806 1845 pancreatic cancer by reprogramming PSCs
T35 Condition 792 797 PDACs
T36 Protein 1445 1449 AMPK
T37 Protein 1043 1048 TGF-ß
T38 Intervention 897 906 metformin
T39 Condition 279 283 PSCs
T40 Condition 1980 2013 overweight diabetic PDAC patients
T41 Level 252 277 pancreatic stellate cells
T42 Condition 279 282 PSC
T43 Level 1101 1115  cultured PSCs
T44 Disease 763 771 fibrosis
T45 Condition 167 172 tumor
T47 Level 263 277 stellate cells
T49 Condition 351 355 PDAC
T50 Condition 301 312 desmoplasia
T52 Intervention 1561 1570 metformin
T54 Protein 1214 1236 inflammatory cytokines
T55 Condition 1165 1170 tumor
T56 Condition 749 752 PSC
T57 Biomarker 601 610 Metformin
T58 Intervention 1467 1476 metformin
T60 Biomarker 357 366 Metformin
T61 Condition 167 184 tumor desmoplasia
T62 Intervention 736 745 metformin
T63 Condition 2000 2004 PDAC
T64 Level 654 668 stellate cells
T65 Condition 1841 1844 PSC
T66 Condition 44 48 PDAC
T67 Condition 828 850 diabetic PDAC patients
T68 Condition 925 930 tumor
T69 Condition 62 80 desmoplastic tumor
